Obesity

Changes in Body Composition Assessed by Bioelectrical Impedance Analysis in Patients Treated With Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Experience

Endocr PractPublished Retrospective cohort study

Authors' conclusion

In real-world clinical practice, GLP-1 RA therapy combined with lifestyle interventions led to substantial improvements in body composition, characterized by predominant fat and visceral fat loss, with minimal skeletal muscle reduction.

Study context

Population
Adults with obesity treated with GLP-1 RAs in a specialized endocrinology clinic; 40.7% women, mean age 50.3 years
Participants
388 adults
Outcome
Body composition changes by multifrequency bioelectrical impedance analysis
Follow-up
6 months
Methodological detailsreal-world observational, single-group, specialized endocrinology clinic, Assessments at baseline, 6 weeks, 3 months and 6 months, Linear mixed models with a random intercept per patient; fully adjusted model for adherence and obesity phenotype
  • Real-world observational
  • Single-group
  • Specialized endocrinology clinic
  • Assessments at baseline, 6 weeks, 3 months and 6 months
  • Linear mixed models with a random intercept per patient; fully adjusted model for adherence and obesity phenotype

Main finding

As reported in the abstract

Body composition changes

Mean weight loss (P < .001)

11.3%

Fat mass reduction

−22%

Visceral fat area decrease

−40.6 cm²

Skeletal muscle mass decrease, modest relative to fat mass reduction

−1.46 kg

Observational data: associations, not effects.

Further findings

Fat loss by adherence

Adherent patients had greater fat loss than non-adherent patients

Anxiety and binge eating behaviors

Improvements in anxiety and binge eating behaviors

Obesity phenotype

Baseline differences and distinct patterns of fat and muscle loss by phenotype

Original publication

Changes in Body Composition Assessed by Bioelectrical Impedance Analysis in Patients Treated With Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Experience. Endocr Pract. Published 19 September 2026. doi:10.1016/j.eprac.2026.09.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.